Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome - ScienceDirect
The prognostic significance of preoperative tumor marker (CEA, CA15-3) elevation in breast cancer patients: data from the Korean Breast Cancer Society Registry | SpringerLink
Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome - ScienceDirect
Elucidating tumor heterogeneity from spatially resolved transcriptomics data by multi-view graph collaborative learning | Nature Communications
![PDF] Analysis of tumour marker CA 15-3 in breast cancer following surgery | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4744f482e3401b93bffb69ba515294512d87cb8d/2-Table1-1.png "PDF] Analysis of tumour marker CA 15-3 in breast cancer following surgery | Semantic Scholar")
PDF] Analysis of tumour marker CA 15-3 in breast cancer following surgery | Semantic Scholar
PDF) Recommendations for medical management of hereditary breast and ovarian cancer: The INSERM-FNCLCC ad hoc committee
An individual reference limit of the serum CEA-TPA-CA 15-3 tumor marke | CMAR
Tumor Markers for Breast Cancer: Benefits, Drawbacks, Results & More
Relationship between preoperative serum markers CA 15-3 and CEA and relapse of the disease in elderly (>65 years) women with breast cancer. | Semantic Scholar
Table 2 from Evaluation of tumor markers in southern Indian breast cancer patients. | Semantic Scholar
CEA and CA 15.3 serum concentrations in patients with primary... | Download Table
Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer | PLOS ONE
Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome - ScienceDirect
Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study | SpringerLink
The CA 15-3 test and breast cancer: What it is and results
Tumor Markers for Breast Cancer: Benefits, Drawbacks, Results & More
Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect
CEA, CA 15-3, and TPS as Prognostic Factors in the Follow-up Monitoring of Patients After Radical Surgery for Breast Cancer | Anticancer Research
Tumor Markers for Breast Cancer: Benefits, Drawbacks, Results & More
Dual Mechanisms of LYN Kinase Dysregulation Drive Aggressive Behavior in Breast Cancer Cells
Prediction of progressive disease using tumor markers in metastatic breast cancer patients without target lesions in first-line chemotherapy - Annals of Oncology
Axillary Lymph Node Metastasis: CA-15-3 and Carcinoembryonic Antigen Concentrations in Fine-Needle Aspirates for Preoperative Diagnosis in Patients with Breast Cancer | Radiology
Preoperative CA 15-3 and CEA serum levels as predictor for breast cancer outcomes - ScienceDirect
Predictive markers for pathological complete response after neo-adjuvant chemotherapy in triple-negative breast cancer - ScienceDirect
M1 macrophages evoke an increase in polymeric immunoglobulin receptor (PIGR) expression in MDA-MB468 breast cancer cells through secretion of interleukin-1β | Scientific Reports
Relationship between tumor markers CEA and CA 15-3 and recurrence breast cancer | Semantic Scholar
Relationship between CA 15-3 serum levels and size of the tumor in the... | Download Scientific Diagram
